Vancin Injection 500 mg/vial contains Vancomycin Hydrochloride 500 mg, a potent glycopeptide antibiotic used for the treatment of serious Gram-positive bacterial infections. It is particularly effective against multi-drug resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, and Enterococcus species.
Vancin Injection is widely used in hospital settings for severe infections where other antibiotics may be ineffective. It provides bactericidal activity by targeting the bacterial cell wall and is essential for treating infections that are resistant to beta-lactam antibiotics. This makes it a critical option for life-threatening infections, complicated skin infections, bone and joint infections, and bloodstream infections.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Vancomycin Hydrochloride 500 mg per vial
Vancomycin, the active ingredient in Vancin Injection, acts by:
Inhibiting bacterial cell wall synthesis – Vancomycin binds to the D-alanyl-D-alanine terminus of cell wall precursors, preventing cross-linking and weakening the bacterial cell wall.
Bactericidal activity – Disruption of the cell wall results in bacterial lysis and death.
Effective against resistant Gram-positive bacteria – Particularly active against MRSA and other beta-lactam-resistant organisms.
Slow resistance development – Maintains efficacy even against some multi-drug resistant strains, making it a valuable option for complicated infections.
This mechanism ensures rapid elimination of bacteria, preventing the spread of infection and improving patient outcomes.
Vancin Injection 500 mg/vial is indicated for:
Severe Gram-positive infections – Including MRSA, MRSE, and Enterococcus infections
Bloodstream infections (bacteremia) – Life-threatening infections requiring intravenous therapy
Complicated skin and soft tissue infections – Including post-surgical wound infections
Bone and joint infections – Osteomyelitis and septic arthritis
Endocarditis – Infections of the heart valves caused by susceptible Gram-positive bacteria
Pneumonia – Particularly hospital-acquired or ventilator-associated infections caused by resistant organisms
It is suitable for adult and pediatric patients under strict medical supervision.
Route: Intravenous (IV) infusion only; never administered as a rapid bolus to avoid adverse reactions.
Adults: Typically 15–20 mg/kg every 8–12 hours depending on infection severity and renal function.
Pediatric patients: Dose calculated based on body weight and clinical condition.
Adjust dosage in patients with renal impairment to prevent toxicity.
Administer slowly over 60 minutes for doses ≤1 g to reduce the risk of “Red Man Syndrome.”
Duration of therapy depends on infection type, severity, and patient response, usually guided by microbiological and clinical outcomes.
Effective against serious and resistant Gram-positive bacterial infections
Critical treatment for MRSA, MRSE, and Enterococcus infections
Provides bactericidal action for rapid infection control
Versatile IV administration suitable for hospital use
Reduces complications associated with severe infections
Monitor renal function during prolonged therapy; adjust dosage if necessary.
Avoid rapid IV administration to prevent infusion-related reactions.
Use cautiously in patients with hypersensitivity to vancomycin.
Pregnancy and breastfeeding: Use only if clearly indicated and prescribed by a physician.
Watch for signs of ototoxicity or nephrotoxicity during long-term use.
Common side effects:
Redness, flushing, or rash at infusion site (“Red Man Syndrome”)
Mild nausea, vomiting, or diarrhea
Fever or chills during infusion
Rare but serious side effects:
Nephrotoxicity or kidney impairment
Ototoxicity, hearing loss, or tinnitus
Severe allergic reactions, including anaphylaxis
Blood disorders such as neutropenia or thrombocytopenia
Store in a cool, dry place below 25°C
Protect from light and moisture
Keep the vial tightly closed until use
Keep out of reach of children
Vancin Injection 500 mg/vial is a powerful antibiotic for managing serious Gram-positive infections, including resistant strains like MRSA, offering rapid bactericidal activity and critical support in hospital-based infection management.
Login Or Registerto submit your questions to seller
No none asked to seller yet